Brian ELLIOTT

Person

Hoboken, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bispecific antibodies against CD3 and CD20 for treating chronic lym...
- Patent number 11,858,995
- Issue date Jan 2, 2024
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibody against CD3 and CD20 in combination therapy for...
- Patent number 11,845,805
- Issue date Dec 19, 2023
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibody against CD3 and CD20 in combination therapy for...
- Patent number 11,608,383
- Issue date Mar 21, 2023
- GENMAB A/S
- Brian Elliott
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibody against CD3 and CD20 in combination therapy for...
- Patent number 11,548,952
- Issue date Jan 10, 2023
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibody against CD3 and CD20 in combination therapy for...
- Patent number 11,535,679
- Issue date Dec 27, 2022
- GENMAB A/S
- Brian Elliott
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20240301078
- Publication date Sep 12, 2024
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 FOR TREATING RICHTER'S S...
- Publication number 20240174761
- Publication date May 30, 2024
- Brian ELLIOTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20240034812
- Publication date Feb 1, 2024
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20230355753
- Publication date Nov 9, 2023
- GENMAB A/S
- Brian ELLIOTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20230357440
- Publication date Nov 9, 2023
- GENMAB A/S
- Brian ELLIOTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 FOR TREATING CHRONIC LYM...
- Publication number 20230312757
- Publication date Oct 5, 2023
- GENMAB A/S
- Brian ELLIOTT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20230312758
- Publication date Oct 5, 2023
- Brian ELLIOTT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20230312759
- Publication date Oct 5, 2023
- GENMAB A/S
- Brian ELLIOTT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20
- Publication number 20230227570
- Publication date Jul 20, 2023
- GENMAB A/S
- Tahamtan AHMADI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20220144964
- Publication date May 12, 2022
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20220119544
- Publication date Apr 21, 2022
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20220112300
- Publication date Apr 14, 2022
- GENMAB A/S
- Brian ELLIOTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 FOR TREATING CHRONIC LYM...
- Publication number 20220112287
- Publication date Apr 14, 2022
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20220112301
- Publication date Apr 14, 2022
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20220112309
- Publication date Apr 14, 2022
- GENMAB A/S
- Brian ELLIOTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20
- Publication number 20210371538
- Publication date Dec 2, 2021
- GENMAB A/S
- Tahamtan AHMADI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Brian ELLIOTT

Person

Patents Grantslast 30 patents

Bispecific antibodies against CD3 and CD20 for treating chronic lym...

Bispecific antibody against CD3 and CD20 in combination therapy for...

Bispecific antibody against CD3 and CD20 in combination therapy for...

Bispecific antibody against CD3 and CD20 in combination therapy for...

Bispecific antibody against CD3 and CD20 in combination therapy for...

Patents Applicationslast 30 patents

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 FOR TREATING RICHTER'S S...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 FOR TREATING CHRONIC LYM...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 FOR TREATING CHRONIC LYM...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20